Search results
Editas (EDIT) Q4 Earnings & Revenues Top Estimates, Stock Up
Zacks via Yahoo Finance· 3 months agoEditas (EDIT) reports better-than-expected fourth-quarter 2023 results as both earnings and revenues...
Editas (EDIT) Posts Upbeat Initial Data From SCD & TDT Studies
Zacks via Yahoo Finance· 12 months agoEditas (EDIT) announces positive preliminary safety and efficacy data from patients treated with its...
Editas (EDIT) Q3 Earnings & Revenues Beat, Pipeline in Focus
Zacks via Yahoo Finance· 7 months agoEditas Medicine, Inc. EDIT incurred a loss of 55 cents per share in the third quarter of 2023,...
Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoEditas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Call Transcript November 3, 2023 Editas...
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
Motley Fool via Yahoo Finance· 3 months agoShares of Editas Medicine (NASDAQ: EDIT) charged sharply higher this week, soaring as much as 41.6%,...
Editas' (EDIT) Loss Narrows in Q2, Revenues Trump Estimates
Zacks via Yahoo Finance· 2 years agoEditas (EDIT) reports a narrower-than-expected loss in the second quarter of 2022 while its revenues...
Could Editas Medicine Become the Next CRISPR Therapeutics?
Motley Fool via Yahoo Finance· 4 months agoEditas Medicine (NASDAQ: EDIT) and CRISPR Therapeutics (NASDAQ: CRSP) share more than a few...
Editas (EDIT) Focuses on Developing Gene-Editing Eye Drug
Zacks via Yahoo Finance· 2 years agoEditas' (EDIT) lead pipeline candidate, EDIT-101, which employs CRISPR gene editing to treat LCA10,...
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
Motley Fool via Yahoo Finance· 5 months agoInvesting in cutting-edge companies is a bit riskier than investing in tried-and-tested players, but...
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
Motley Fool via Yahoo Finance· 5 months agoIt's fair to say that Editas Medicine (NASDAQ: EDIT) is an ailing biotech. Over the past three...